[Federal Register Volume 85, Number 170 (Tuesday, September 1, 2020)]
[Notices]
[Pages 54344-54345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19258]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-25-2020]


Foreign-Trade Zone (FTZ) 26--Atlanta; Georgia, Authorization of 
Production Activity, Janssen Pharmaceuticals Inc. (Pharmaceutical 
Products) Athens, Georgia

    On April 29, 2020, Janssen Pharmaceuticals Inc., submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 26K, in Athens, Georgia.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including

[[Page 54345]]

notice in the Federal Register inviting public comment (85 FR 27205-
27206, May 7, 2020). On August 27, 2020, the applicant was notified of 
the FTZ Board's decision that no further review of the activity is 
warranted at this time. The production activity described in the 
notification was authorized, subject to the FTZ Act and the FTZ Board's 
regulations, including Section 400.14.

    Dated: August 27, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020-19258 Filed 8-31-20; 8:45 am]
BILLING CODE 3510-DS-P